Zobrazeno 1 - 10
of 16
pro vyhledávání: '"MESH : Vascular Endothelial Growth Factor Receptor-2"'
Autor:
Shahragim Tajbakhsh, Cédric Thépenier, David Briand, Aurélie Guguin, Aurore Besnard, Mathilde Latil, Pierre Rocheteau, Grégory Jouvion, Jean-Marc Cavaillon, Quentin Pascal, Fabrice Chrétien, David Hardy, Barbara Gayraud-Morel
Publikováno v:
PLoS ONE
PLoS ONE, Public Library of Science, 2016, 11 (1), pp.e0147198. 〈10.1371/journal.pone.0147198〉
PLoS ONE, 2016, 11 (1), pp.e0147198. ⟨10.1371/journal.pone.0147198⟩
PLoS ONE, Vol 11, Iss 1, p e0147198 (2016)
PLoS ONE, Public Library of Science, 2016, 11 (1), pp.e0147198. ⟨10.1371/journal.pone.0147198⟩
PLoS ONE, Public Library of Science, 2016, 11 (1), pp.e0147198. 〈10.1371/journal.pone.0147198〉
PLoS ONE, 2016, 11 (1), pp.e0147198. ⟨10.1371/journal.pone.0147198⟩
PLoS ONE, Vol 11, Iss 1, p e0147198 (2016)
PLoS ONE, Public Library of Science, 2016, 11 (1), pp.e0147198. ⟨10.1371/journal.pone.0147198⟩
International audience; A longstanding goal in regenerative medicine is to reconstitute functional tissues or organs after injury or disease. Attention has focused on the identification and relative contribution of tissue specific stem cells to the r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9a59bf3798e0703ed6ee10e60a0ec30
https://hal-pasteur.archives-ouvertes.fr/pasteur-01447903
https://hal-pasteur.archives-ouvertes.fr/pasteur-01447903
Publikováno v:
Cellular and Molecular Life Sciences
Cellular and Molecular Life Sciences, 2013, 70 (10), pp.1685-703. ⟨10.1007/s00018-013-1278-4⟩
Cellular and Molecular Life Sciences, Springer Verlag, 2013, 70 (10), pp.1685-703. ⟨10.1007/s00018-013-1278-4⟩
Cellular and Molecular Life Sciences, 2013, 70 (10), pp.1685-703. ⟨10.1007/s00018-013-1278-4⟩
Cellular and Molecular Life Sciences, Springer Verlag, 2013, 70 (10), pp.1685-703. ⟨10.1007/s00018-013-1278-4⟩
International audience; Many organs, such as lungs, nerves, blood and lymphatic vessels, consist of complex networks that carry flows of information, gases, and nutrients within the body. The morphogenetic patterning that generates these organs invol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4808adbe8a013f90ee5f665c9e4ccde6
https://doi.org/10.1007/s00018-013-1278-4
https://doi.org/10.1007/s00018-013-1278-4
Autor:
Samira Mihoubi, Edith Beaulieu, Denis Gingras, Richard Béliveau, David Ratel, Yves Durocher, Georges-Etienne Rivard
Publikováno v:
Thrombosis Research
Thrombosis Research, Elsevier, 2007, 121 (2), pp.203-12. ⟨10.1016/j.thromres.2007.03.024⟩
Thrombosis Research, Elsevier, 2007, 121 (2), pp.203-12. ⟨10.1016/j.thromres.2007.03.024⟩
International audience; Proteolysis of fibrin matrices by endothelial cells plays essential roles in the migratory and morphogenic differentiation processes underlying angiogenesis. Using an in vitro fibrinolysis model consisting of human umbilical v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1953e5e85909b29b51f2118d321b60fe
https://doi.org/10.1016/j.thromres.2007.03.024
https://doi.org/10.1016/j.thromres.2007.03.024
Autor:
Khayati, F., Pérez-Cano, L., Maouche, K., Sadoux, A., Boutalbi, Z., Podgorniak, M. -P, Maskos, U., Setterblad, N., Janin, A., Calvo, F., Lebbé, C., Menashi, S., Juan Fernandez-Recio, Mourah, S.
Publikováno v:
Oncotarget
Oncotarget, 2015, 6 (12), pp.9766-80. ⟨10.18632/oncotarget.2870⟩
Scopus-Elsevier
Recercat. Dipósit de la Recerca de Catalunya
instname
UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)
Oncotarget, Impact journals, 2015, 6 (12), pp.9766-80. ⟨10.18632/oncotarget.2870⟩
Oncotarget, 2015, 6 (12), pp.9766-80. ⟨10.18632/oncotarget.2870⟩
Scopus-Elsevier
Recercat. Dipósit de la Recerca de Catalunya
instname
UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)
Oncotarget, Impact journals, 2015, 6 (12), pp.9766-80. ⟨10.18632/oncotarget.2870⟩
EMMPRIN/CD147 is mainly known for its protease inducing function but a role in promoting tumor angiogenesis has also been demonstrated. This study provides evidence that EMMPRIN is a new coreceptor for the VEGFR-2 tyrosine kinase receptor in both end
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::eac3a2c32572c88b8a51a0f370a5f14a
https://hdl.handle.net/2117/84621
https://hdl.handle.net/2117/84621
Publikováno v:
Trends in Cardiovascular Medicine
Trends in Cardiovascular Medicine, Elsevier, 2006, 16 (2), pp.55-9. ⟨10.1016/j.tcm.2005.11.008⟩
Trends in Cardiovascular Medicine, 2006, 16 (2), pp.55-9. ⟨10.1016/j.tcm.2005.11.008⟩
Trends in Cardiovascular Medicine, Elsevier, 2006, 16 (2), pp.55-9. ⟨10.1016/j.tcm.2005.11.008⟩
Trends in Cardiovascular Medicine, 2006, 16 (2), pp.55-9. ⟨10.1016/j.tcm.2005.11.008⟩
International audience; Because angiogenesis is a key step in a number of pathologic processes, including tumor growth and atherosclerosis, many research studies have investigated the regulatory signals active at various stages of vascular invasion.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d04aea7ae3962e2abd0c56c475d6378
https://doi.org/10.1016/j.tcm.2005.11.008
https://doi.org/10.1016/j.tcm.2005.11.008
Autor:
Ruxandra Hera, Michel Mouillon, Jean-Paul Romanet, Jean-Jacques Feige, Michel Peoc'h, Michelle Keramidas
Publikováno v:
American Journal of Ophthalmology
American Journal of Ophthalmology, Elsevier Masson, 2005, 139 (4), pp.589-96. ⟨10.1016/j.ajo.2004.11.064⟩
American Journal of Ophthalmology, 2005, 139 (4), pp.589-96. ⟨10.1016/j.ajo.2004.11.064⟩
American Journal of Ophthalmology, Elsevier Masson, 2005, 139 (4), pp.589-96. ⟨10.1016/j.ajo.2004.11.064⟩
American Journal of Ophthalmology, 2005, 139 (4), pp.589-96. ⟨10.1016/j.ajo.2004.11.064⟩
International audience; PURPOSE: Vascular endothelial growth factor (VEGF) and angiopoietins are key regulators of angiogenesis. The purpose of this study was to measure mRNA levels of these factors and of their receptors in surgically excised subfov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cbc15c1c9abf975947c8144d5aae404
https://doi.org/10.1016/j.ajo.2004.11.064
https://doi.org/10.1016/j.ajo.2004.11.064
Autor:
Joseph-Philippe Etievent, Nicolas Meneveau, Frédéric Deschaseaux, Pierre-Emmanuel Falcoz, Nursen Mersin, Pierre Tiberghien, Zohair Selmani, Alfred Penfornis, Sidney Chocron, C. Kleinclauss, Jean-Pierre Kantelip, Siamak Davani
Publikováno v:
European Journal of Pharmacology
European Journal of Pharmacology, Elsevier, 2007, 562 (1-2), pp.111-8. ⟨10.1016/j.ejphar.2007.01.045⟩
European Journal of Pharmacology, Elsevier, 2007, 562 (1-2), pp.111-8. 〈10.1016/j.ejphar.2007.01.045〉
European Journal of Pharmacology, Elsevier, 2007, 562 (1-2), pp.111-8. ⟨10.1016/j.ejphar.2007.01.045⟩
European Journal of Pharmacology, Elsevier, 2007, 562 (1-2), pp.111-8. 〈10.1016/j.ejphar.2007.01.045〉
International audience; 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are widely used to decrease cholesterol synthesis and are well established to reduce vascular diseases. Recently, it has been proposed that statins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10f724e9793befc717dc74b9fd9da39a
https://pubmed.ncbi.nlm.nih.gov/17320859
https://pubmed.ncbi.nlm.nih.gov/17320859
Autor:
Matthieu, Talagas, Arnaud, Uguen, Ronan, Garlantezec, Georges, Fournier, Laurent, Doucet, Eric, Gobin, Pascale, Marcorelles, Alain, Volant, Marc, DE Braekeleer
Publikováno v:
Anticancer Research
Anticancer Research, International Institute of Anticancer Research, 2013, 33 (5), pp.2065-75
Anticancer Research, International Institute of Anticancer Research, 2013, 33 (5), pp.2065-75
International audience; Prostate cancer can usually be treated at a clinically localized stage by radical prostatectomy. Unfortunately, within 10 years following surgery, 30% of patients experience local or distant relapse. Few data exist on the asso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b33861d019698871354aafb1c518e853
https://hal.archives-ouvertes.fr/hal-00876427
https://hal.archives-ouvertes.fr/hal-00876427
Autor:
Mahdi Behdani, Nader Asadzadeh, Serge Muyldermans, Keyhan Azadmanesh, Gholamreza Hassanzadeh-Ghassabeh, Steve Schoonooghe, Alireza Khabiri, Mahdi Habibi Anbouhi, Morteza Karimipour, Hossein Khanahmad, Sirous Zeinali
Publikováno v:
Molecular Immunology
Molecular Immunology, Elsevier, 2012, 50 (1-2), pp.35-41. ⟨10.1016/j.molimm.2011.11.013⟩
Vrije Universiteit Brussel
Molecular Immunology, Elsevier, 2012, 50 (1-2), pp.35-41. ⟨10.1016/j.molimm.2011.11.013⟩
Vrije Universiteit Brussel
International audience; Vascular endothelial growth factor receptor-2 (VEGFR2) is an important tumor-associated receptor and blockade of the VEGF receptor signaling can lead to the inhibition of neovascularization and tumor metastasis. Nanobodies are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8ad5ff225a948ca56e5e3a955a1b7f2
https://biblio.vub.ac.be/vubir/generation-and-characterization-of-a-functional-nanobody-against-the-vascular-endothelial-growth-factor-receptor2-angiogenesis-cell-receptor(52744170-4794-471b-9ba4-a61f18f87c3d).html
https://biblio.vub.ac.be/vubir/generation-and-characterization-of-a-functional-nanobody-against-the-vascular-endothelial-growth-factor-receptor2-angiogenesis-cell-receptor(52744170-4794-471b-9ba4-a61f18f87c3d).html
Autor:
Besse, Sophie, Boucher, François, Linguet, Gilberte, Riou, Laurent, De Leiris, Joël, Riou, Bertrand, Dimastromatteo, Julien, Comte, René, Courty, José, Delbe, Jean
Publikováno v:
Journal of Physiology and Pharmacology
Journal of Physiology and Pharmacology, Krakow Polish Physiological Society, 2010, 61 (6), pp.651-61
Europe PubMed Central
ResearcherID
Journal of Physiology and Pharmacology, Krakow Polish Physiological Society, 2010, 61 (6), pp.651-61
Europe PubMed Central
ResearcherID
International audience; Myocardial capillary density and angiogenesis are impaired during aging but whether growth factor therapy is able to induce functional neovascularization in senescent heart have never been studied. In 3, 24, 28 and 32 mo male
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3cb523bcfd0a9b972e6595798136f028
https://pubmed.ncbi.nlm.nih.gov/21224495
https://pubmed.ncbi.nlm.nih.gov/21224495